Importance of homocysteine, lipoprotein (a) and non-classical cardiovascular risk factors (fibrinogen and advanced glycation end-products) for atherogenesis in uraemic patients.
Massy
Z A
ZA
Division of Nephrology, CH Beauvais and INSERM U507, Necker Hospital, Paris, France.
D001161:Arteriosclerosis / Q000097:blood / Q000209:etiology*; D015415:Biomarkers / Q000097:blood; D005340:Fibrinogen / Q000378:metabolism; D017127:Glycation End Products, Advanced / Q000097:blood*; D006710:Homocysteine / Q000097:blood*; D006801:Humans; D017270:Lipoprotein(a) / Q000097:blood*; D012307:Risk Factors; D014511:Uremia / Q000097:blood / Q000150:complications*
D015415:Biomarkers; D017127:Glycation End Products, Advanced; D017270:Lipoprotein(a); D006710:Homocysteine; D005340:Fibrinogen